ArticleThe oncologist2017

Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.

Anthony F Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.